Preventive Maintenance, Service, Support, and Coverage for (1) Government-Owned AutoGen GENEPREP with Stacker - automated DNA isolation machine
Closed Special Notice Posted
- Solicitation number
- 75N91026Q00081
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute (NCI), part of the Department of Health and Human Services Office of the Assistant Secretary for Administration, issued this Special Notice on March 13, 2026, regarding a sole source procurement for preventive maintenance services. This is a Notice of Intent to Award, not a Request for Quotations, under Federal Acquisition Regulation (FAR) Subpart 13.106-1(b). The NCI intends to award a single source purchase order to Autogen Inc. for maintenance services on a government-owned GENEPREP with Stacker automated DNA isolation machine. The procurement is classified under NAICS code 811210 (Electronic and Precision Equipment Repair and Maintenance) with a size standard of $34 million. The Special Notice was posted on March 13, 2026, with a deadline for interested parties to respond by March 19, 2026.
The objective of this procurement is to secure annual preventive maintenance services for the GENEPREP instrument used by the Experimental Immunology Branch for daily laboratory operations involving plasmid and genomic DNA isolation. The contract period of performance runs from March 23, 2026, through March 22, 2027, and will include all labor, materials, and equipment necessary for preventive maintenance conducted according to the manufacturer's standard practices. Although the government intends to negotiate directly with Autogen Inc., interested parties may submit a written statement of capabilities demonstrating their ability to meet the requirements, provided such statements contain sufficient detail for evaluation. No competitive solicitation will be issued, and award is contingent upon approval of the sole source justification. This opportunity is available to contractors who can demonstrate expertise in electronic and precision equipment repair and maintenance services.
Notice text
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE ORDER AND NOT A REQUEST FOR QUOTATIONS. This contract action is for the acquisition of services for which the Government intends to solicit and negotiate with only one source under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b). The National Cancer Institute (NCI) intends to award a single source purchase order to Autogen Inc., 84 October Hill Road, Holliston, MA 01746-1371, for the acquisition of preventative maintenance for the government-owned GENEPREP w/ Stacker instrument (S/N 481102/825056).
The National Cancer Institute (NCI), Experimental Immunology Branch (EIB), needs to obtain the annual preventative service maintenance agreement for a clinical instrument (GENEPREP w/ Tracker) which is used daily in a variety of experiments by many users. The GENEPREP is a fully automated plasmid and genomic DNA isolation workflow instrument. The instrument’s service shall consist of all labor, material and equipment for preventive maintenance on this machine. All maintenance services shall be performed in accordance with the manufacturer's standard maintenance practices.
The anticipated period of performance will be from March 23, 2026 through March 22, 2027.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 811210 – Electronic and Precision Equipment Repair and Maintenance and a size standard of $34M.
NCI will solicit and negotiate directly with Autogen Inc. and no solicitation will be issued. Interested parties may identify their interest and capability. Award is subject to approval of the Sole Source Justification. This notice of intent is not a request for competitive proposals or quotations; however, an interested party may submit a statement of capabilities if they believe they can meet the above requirement. The statement of capabilities must be submitted in writing and contain sufficient detail to allow the Government to determine if the party can provide the requirement. A determination by the Government not to compete this proposed action based upon responses to this notice is solely with the discretion of the Government.
All responses must be received by Thursday, March 19, 2026. Information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received by March 19, 2026, an award will be made to Autogen Inc. This procurement is to be processed using Simplified Acquisition Procedures. There is no solicitation package available. For any questions regarding this announcement, please contact Rita Davis via email rita.davis@hhs.gov.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity